Rodolfo Gonzalez
Affiliations: | 2011- | Scripps Research Institute |
Google:
"Rodolfo Gonzalez"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lee JP, Zhang R, Yan M, et al. (2020) Chemical mutagenesis of a GPCR ligand: Detoxifying "inflammo-attraction" to direct therapeutic stem cell migration. Proceedings of the National Academy of Sciences of the United States of America |
| Lee JY, Acosta S, Tuazon JP, et al. (2019) Human parthenogenetic neural stem cell grafts promote multiple regenerative processes in a traumatic brain injury model. Theranostics. 9: 1029-1046 |
| Gonzalez R, Garitaonandia I, Semechkin A, et al. (2019) Derivation of Neural Stem Cells from Human Parthenogenetic Stem Cells. Methods in Molecular Biology (Clifton, N.J.). 1919: 43-57 |
| Garitaonandia I, Gonzalez R, Sherman G, et al. (2018) Novel Approach to Stem Cell Therapy in Parkinson's Disease. Stem Cells and Development |
| Christiansen-Weber T, Noskov A, Cardiff D, et al. (2018) Supplementation of Specific Carbohydrates Results in Enhanced Deposition of Chondrogenic-Specific Matrix during Mesenchymal Stem Cell Differentiation. Journal of Tissue Engineering and Regenerative Medicine |
| Gonzalez R, Garitaonandia I, Poustovoitov M, et al. (2016) Neural Stem Cells Derived From Human Parthenogenetic Stem Cells Engraft and Promote Recovery in a Nonhuman Primate Model of Parkinsons Disease. Cell Transplantation. 25: 1945-1966 |
| Garitaonandia I, Gonzalez R, Christiansen-Weber T, et al. (2016) Neural Stem Cell Tumorigenicity and Biodistribution Assessment for Phase I Clinical Trial in Parkinson's Disease. Scientific Reports. 6: 34478 |
| Gonzalez R, Hamblin MH, Lee JP. (2016) Neural Stem Cell Transplantation and CNS Diseases. Cns & Neurological Disorders Drug Targets |
| Gonzalez R, Garitaonandia I, Poustovoitov M, et al. (2016) Neural Stem Cells Derived from Human Parthenogenetic Stem Cells Engraft and Promote Recovery in a Nonhuman Primate Model of Parkinson's Disease. Cell Transplantation |
| Eckert A, Huang L, Gonzalez R, et al. (2015) Bystander Effect Fuels Human Induced Pluripotent Stem Cell-Derived Neural Stem Cells to Quickly Attenuate Early Stage Neurological Deficits After Stroke. Stem Cells Translational Medicine. 4: 841-51 |